当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析

科兴制药

(688136)

  

流通市值:85.09亿  总市值:85.09亿
流通股本:2.01亿   总股本:2.01亿

科兴制药(688136)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.79亿元,每股收益0.41元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益168511.34万元,未分配利润21639.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产331829.37万元,负债163318.03万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入700,464,766.25353,559,464.741,406,925,448.31,038,255,976.88
营业总成本653,551,426.35323,281,678.191,344,390,356.12975,684,606.8
其他经营收益
营业利润86,211,621.5534,117,948.0163,200,515.5555,728,103.27
利润总额84,128,950.231,785,499.9156,902,608.1549,890,510.3
净利润78,962,472.0624,851,106.7627,048,555.413,749,491.01
每股收益
其他综合收益-25,544.5-3,532.561,119,696.97357,532.77
综合收益总额78,936,927.5624,847,574.228,168,252.3714,107,023.78
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,432,193,326.281,323,937,686.61,287,809,760.091,123,094,074.07
非流动资产:
非流动资产合计1,886,100,348.921,869,781,558.191,874,424,768.071,877,099,374.56
资产总计3,318,293,675.23,193,719,244.793,162,234,528.163,000,193,448.63
流动负债:
流动负债合计913,266,791.04882,260,873.66886,397,364.11762,936,045.47
非流动负债:
非流动负债合计719,913,485.41643,553,980.61636,590,505.55616,901,503.97
负债合计1,633,180,276.451,525,814,854.271,522,987,869.661,379,837,549.44
所有者权益(或股东权益):
归属于母公司股东权益合计1,682,157,277.011,664,292,398.751,634,908,540.581,615,014,203.94
股东权益合计1,685,113,398.751,667,904,390.521,639,246,658.51,620,355,899.19
负债和股东权益合计3,318,293,675.23,193,719,244.793,162,234,528.163,000,193,448.63
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计606,518,800.32310,620,690.741,199,675,882.57895,292,225.18
经营活动现金流出小计576,720,717.59285,175,543.11,093,006,146.16842,023,010.64
经营活动产生的现金流量净额29,798,082.7325,445,147.64106,669,736.4153,269,214.54
投资活动产生的现金流量:
投资活动现金流入小计825,010,393.29348,927,679.481,959,318,497.971,490,644,676.85
投资活动现金流出小计1,026,375,715.58459,264,017.932,063,443,839.641,725,561,951.91
投资活动产生的现金流量净额-201,365,322.29-110,336,338.45-104,125,341.67-234,917,275.06
筹资活动产生的现金流量:
筹资活动现金流入小计440,049,226.94176,879,579.9634,619,783.9436,755,263.9
筹资活动现金流出小计376,233,605.33156,215,255.49645,533,991.09511,240,285.27
筹资活动产生的现金流量净额63,815,621.6120,664,324.41-10,914,207.19-74,485,021.37
汇率变动对现金及现金等价物的影响1,033,973.31449,313.931,391,169.29731,760.74
现金及现金等价物净增加额-106,717,644.64-63,777,552.47-6,978,643.16-255,401,321.15
期末现金及现金等价物余额446,234,297.95489,420,850.82552,951,942.59304,529,264.6
补充资料:
现金及现金等价物的净增加额-106,717,644.64--6,978,643.16-
最新报告期:2025-09-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券谭国超0.701.021.672025-09-12
华源证券刘闯0.601.031.722025-09-08
申万宏源仰佳佳0.541.021.322025-08-31
华源证券刘闯0.531.031.722025-07-17
TOP↑